<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/536F86BC-EBF8-4501-83B6-B6F27C65DC82"><gtr:id>536F86BC-EBF8-4501-83B6-B6F27C65DC82</gtr:id><gtr:name>Quest Diagnostics</gtr:name><gtr:address><gtr:line1>San Juan Capistrano</gtr:line1><gtr:postCode>CA 92690</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/89DB4E4C-8508-44EF-A569-A38E0ED27CA8"><gtr:id>89DB4E4C-8508-44EF-A569-A38E0ED27CA8</gtr:id><gtr:name>University of Dublin</gtr:name><gtr:address><gtr:line1>University of Dublin</gtr:line1><gtr:line2>Trinity College</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/E7910513-EA16-41B2-A0C0-7F49C936A4BF"><gtr:id>E7910513-EA16-41B2-A0C0-7F49C936A4BF</gtr:id><gtr:name>University of Wales</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>University Registry</gtr:line1><gtr:line2>King Edward VII Ave</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:postCode>CF10 3NS</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E7910513-EA16-41B2-A0C0-7F49C936A4BF"><gtr:id>E7910513-EA16-41B2-A0C0-7F49C936A4BF</gtr:id><gtr:name>University of Wales</gtr:name><gtr:address><gtr:line1>University Registry</gtr:line1><gtr:line2>King Edward VII Ave</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:postCode>CF10 3NS</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/536F86BC-EBF8-4501-83B6-B6F27C65DC82"><gtr:id>536F86BC-EBF8-4501-83B6-B6F27C65DC82</gtr:id><gtr:name>Quest Diagnostics</gtr:name><gtr:address><gtr:line1>San Juan Capistrano</gtr:line1><gtr:postCode>CA 92690</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/19185705-3FB8-4C9C-B8F4-D5D7EA64F57F"><gtr:id>19185705-3FB8-4C9C-B8F4-D5D7EA64F57F</gtr:id><gtr:name>National Center for Biotechnology Information (NCBI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56"><gtr:id>DCEC74AE-6E7C-40FC-BFCA-C52990BCEE56</gtr:id><gtr:name>School of Clinical Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/89DB4E4C-8508-44EF-A569-A38E0ED27CA8"><gtr:id>89DB4E4C-8508-44EF-A569-A38E0ED27CA8</gtr:id><gtr:name>University of Dublin</gtr:name><gtr:address><gtr:line1>University of Dublin</gtr:line1><gtr:line2>Trinity College</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/31306DBD-0EEB-4684-9CA0-B35B5C0B52F1"><gtr:id>31306DBD-0EEB-4684-9CA0-B35B5C0B52F1</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Owen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A64B614B-387F-4A87-8F08-18C3C2916676"><gtr:id>A64B614B-387F-4A87-8F08-18C3C2916676</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B09A5C71-5A14-44F8-A31B-7638568AD228"><gtr:id>B09A5C71-5A14-44F8-A31B-7638568AD228</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Holmans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9B8C6561-A7B1-4005-94C5-F62552C54593"><gtr:id>9B8C6561-A7B1-4005-94C5-F62552C54593</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Lovestone</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B1FE4EBC-AF3A-4AE4-A2ED-4BD58E1E2544"><gtr:id>B1FE4EBC-AF3A-4AE4-A2ED-4BD58E1E2544</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Conlon</gtr:otherNames><gtr:surname>O'Donovan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8EA10754-DD93-46BB-8A88-4BE9B3E13EE2"><gtr:id>8EA10754-DD93-46BB-8A88-4BE9B3E13EE2</gtr:id><gtr:firstName>Lesley</gtr:firstName><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300429"><gtr:id>7107C498-81E0-4637-B19A-F60D7586F0A9</gtr:id><gtr:title>Detecting Susceptibility Genes for Late-Onset Alzheimer s Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300429</gtr:grantReference><gtr:abstractText>Alzheimer s disease (AD) is a serious debilitating disorder which costs society more than stroke, heart disease and cancer combined. As more people survive to a greater age, the number of AD sufferers is likely to grow considerably. In recent years the identification of some of the genes involved in AD has resulted in a deeper understanding of how the disease develops. However, there are more genes involved, especially in the common forms of AD with onset in later life. This programme of research aims to identify a gene or genes in a region of chromosome 10 showing very strong evidence of containing at least one susceptibility gene for late-onset AD. We will screen this region intensively using a large sample of over 3000 individuals (MRC Genetic Resource for AD) with AD and without. We will also look for relationships between AD and genes showing compelling evidence of functional involvement in other chromosomal regions likely to contain genes. Finally, we will follow-up the MRC Genetic Resource to produce a sample capable of detecting genes which modify disease symptoms (e.g. Psychosis) and course, as well as those that increase disease risk. The knowledge gained from identifying new genes for AD will provide an important platform for future therapeutic developments.</gtr:abstractText><gtr:technicalSummary>Alzheimer?s disease (AD) is a common debilitating disorder with a prevalence that rises steeply with age from below 1% at 65 years to as high as 40% after the age of 90. Current projections suggest that the number of elderly will double in the next generation, resulting in more than a billion people over the age of 60 by 2025 in Europe alone. In the UK the direct costs of AD are between 7 and 14 billion pounds per year, approximately the same as those of stroke, heart disease and cancer combined. The predicted increase in the prevalence of AD will undoubtedly have an enormous impact on society. Therefore, gaining a more complete understanding of the genetic contribution to AD must be a priority, as it will provide a strong platform for the development of future preventative and therapeutic strategies. There is no doubt that genes play an important role in the aetiology of late-onset AD, the most common form of Alzheimer s disease (LOAD). This research programme seeks to identify novel genes contributing to the risk and/or the course of LOAD. There is compelling evidence for a gene or genes on chromosome 10. We will localize the peak/s within this region using high density linkage in a large series of families with AD.

We will identify the susceptibility genes in the peak/s, using linkage disequilibrium mapping and direct gene analysis. In addition, we will test for association between AD and functional candidate genes in other regions of linkage throughout the genome. Finally, we will maintain and consolidate the largest case-control sample available to the AD genetics research community and create a resource capable of identifying disease modifying, as well as disease susceptibility genes.</gtr:technicalSummary><gtr:fund><gtr:end>2010-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1734881</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry (IoP)</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>3A044487-700F-472E-A002-71B1BF5498C6</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Genetics</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>DFDEF81E-95F4-4F9C-996C-5CEB683F4EA1</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Clinical collection supply agreement to investigate the genetics of Alzheimer's disease</gtr:description><gtr:id>27480C61-E1CF-4A03-863C-8BFAA8A5AA11</gtr:id><gtr:impact>17998437 19013250</gtr:impact><gtr:partnerContribution>GSK funded the collection and storage of DNA samples and clinical and neuroimaging measures on 200 Alzheimer's disease cases in the early stages of disease.</gtr:partnerContribution><gtr:piContribution>We collected 200 AD cases with full clinical work up including volumetric neuroimaging and DNA sampling.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Quest Diagnostics</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Celera Diagnostics</gtr:department><gtr:description>Finding genes for late onset Alzheimer's disease: Collaboration between Washington University, NIMH, Cardiff University and Celera Diagnostics</gtr:description><gtr:id>0FCB1EBB-0411-4C2F-9794-C62302A98384</gtr:id><gtr:impact>17949987 17492769 17725986 18063669 16161859 16385451 16278862 16847012 17317784</gtr:impact><gtr:partnerContribution>Our collaborative group including Celera Diagnostics, Allison Goate and John Hardys research groups undertook a genomewide association study of Alzheimer's disease using genetic pooling and also tested associations with candidate genes. Celera Diagnostics through a sub-contract with MERCK paid for the genomewide association genotyping. Our group took the lead on some studies and contributed samples and intellectual input on others but at all stages all decisions about research design etc were undertaken jointly in a full collaborative fashion. This built on a previous collaboration between ourselves and Allison Goates group from Washington University which spanned over a decade.</gtr:partnerContribution><gtr:piContribution>We undertook a genomewide association study of Alzheimer's disease using genetic pooling and also tested associations with candidate genes. The Celera Diagnostics through a sub-contract with MERCK paid for the genomewide association genotyping. Our group took the lead on some studies and contributed samples and intellectual input on others but at all stages all decisions about research design etc were undertaken jointly in a full collaborative fashion. This built on a previous collaboration between ourselves and Allison Goates group from Washington University which spanned over a decade.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Developmental Neurobiology</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>5E4E33CC-B97F-45D0-96BB-FF707C6A9AE7</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Trinity College Dublin</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>E46C21D2-BF1A-4E4C-8BE4-FB7CBE67B8B4</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Clinical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Public Health and Primary Care</gtr:department><gtr:description>MRC AD Cohort</gtr:description><gtr:id>D2A307FD-BD33-4B97-A6FE-EDE9ADBF4B19</gtr:id><gtr:impact>16970641 17322133 17530621 17440948 17440933 17373700 17999207 18163421</gtr:impact><gtr:partnerContribution>The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.
The MRC AD cohort was collected with MRC funding in a previous grant. This collaboration continues to function looking at candidate genes and candidate regions testing for association with AD and further enriching our clinical data longitudinally, on the remaining members of the cohort. A proportion of this research was directly funded by the MRC grant in question.</gtr:partnerContribution><gtr:piContribution>We contributed DNA, clinical follow up information, genotyping and other laboratory work and complex data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Biotechnology Information (NCBI)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Genome-wide Association Study Collaboration</gtr:department><gtr:description>Genome-wide Association Studies</gtr:description><gtr:id>E8618F28-AC9D-4BD7-A9E1-6297F6CCD193</gtr:id><gtr:impact>The study, published in Nature Genetics (PubMed ID 19734902), has uncovered two new genes associated with Alzheimer's disease. Previously only one gene, APOE4, had been shown to be a risk factor for Alzheimer's disease. The study reveals, for the first time, that two further genes, CLU and PICALM, are related to Alzheimer's disease. This has led to worldwide media coverage. The data produced is still used in new studies with requests coming in to the host institution every few weeks.</gtr:impact><gtr:partnerContribution>This group of 45 collaborators all contributed towards the centres Genome-wide association study</gtr:partnerContribution><gtr:piContribution>Led and co-ordinated the study that involved the work of the following collaborators:
1 MRC Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
2 NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College, London, UK.
3 Department of Neuroscience, Institute of Psychiatry, Kings College, London, UK.
4 Institute of Public Health, University of Cambridge, Cambridge, UK.
5 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
6 Mercer's Institute for Research on Aging, St. James Hospital and Trinity College, Dublin, Ireland.
7 Institute of Genetics, Queen's Medical Centre, University of Nottingham, NG7 2UH, UK.
8 Ageing Group, Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, UK.
9 Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, UK.
10 Clinical Neuroscience Research Group, Greater Manchester Neurosciences Centre, University of Manchester, Salford, UK.
11 Oxford Project to Investigate Memory and Ageing (OPTIMA), University of Oxford, Level 4, John Radcliffe Hospital, Oxford OX3 9DU, UK.
12 Dementia Research Group, University of Bristol Institute of Clinical Neurosciences, Frenchay Hospital, Bristol, UK.
13 Department of Molecular Neuroscience and Reta Lilla Weston Laboratories, Institute of Neurology, London, UK.
14 MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
15 Dementia Research Centre, Department of Neurodegenerative Diseases, University College London, Institute of Neurology, London, UK.
16 Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany.
17 Institute of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Germany.
18 Department of Psychiatry, Charit&amp;eacute; Berlin, Germany.
19 Department of Psychiatry and Psychotherapy, University of Erlangen-N&amp;uuml;remberg, Germany.
20 LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, University Duisburg-Essen, Germany.
21 Institute for Stroke and Dementia Reserach, Klinikum der Universit&amp;auml;t M&amp;uuml;nchen, Marchioninistr. 15, 81377, Munich, Germany.
22 Department of Neurology, Klinikum der Universit&amp;auml;t M&amp;uuml;nchen, Marchioninistr. 15, 81377, Munich, Germany.
23 Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Square J5, D-68161 Mannheim, Germany.
24 Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Laboratory of Neuroimaging &amp;amp; Biomarker Research, Trinity College, University of Dublin, Ireland.
25 Alzheimer Memorial Center and Geriatric Psychiatry Branch, Department of Psychiatry, Ludwig-Maximilian University, Munich, Germany.
26 Centre for Geriatric Medicine and Section of Gerontopsychiatry and Neuropsychology, Medical School, University of Freiburg, Germany.
27 Departments of Psychiatry, Neurology and Genetics, Washington University School of Medicine, St Louis, MO 63110, US.
28 Department of Biology, Brigham Young University, Provo, UT, 84602, USA.
29 Neurodegenerative Brain Diseases group, Department of Molecular Genetics, VIB, Antwerpen, Belgium.
30 Institute Born-Bunge and University of Antwerp; Antwerpen, Belgium.
31 Memory Clinic and Department of Neurology, ZNA Middelheim, Antwerpen, Belgium.
32 Department of Mental Health Sciences, University College London, UK.
33 The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
34 MRC Centre for Neurodegeneration Research, Department of Clinical Neuroscience, King's College London, Institute of Psychiatry, London, SE5 8AF, UK.
35 3rd Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
36 Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.
37 Department of Genomics, Life &amp;amp; Brain Center, University of Bonn, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany.
38 Institute of Human Genetics, University of Bonn, Wilhelmstr. 31, D-53111 Bonn, Germany.
39 Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, University Duisburg-Essen, Hufelandstr. 55, D-45147 Essen, Germany.
40 Institute of Epidemiology, Helmholtz Zentrum M&amp;uuml;nchen, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
41 Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universit&amp;auml;t, Munich, Germany.
42 Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA.
43 Division of Biomedical Statistics and Informatics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>IWA's Agenda magazine</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CD011CF7-528F-4399-AF17-751CCC02AFDC</gtr:id><gtr:impact>Professor Julie Williams' Alzheimer's research is featured in the summer edition of IWA's Agenda magazine (Agenda, No 41 Agenda, Front Page and Pgs 48-49) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of AD</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>69AF203D-DE9B-4CE8-A334-5BDEBDBC6987</gtr:id><gtr:impact>Rome 28th February 2011 - Invited speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Funding for Alzheimer's research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>08EC39D6-BEA0-48FA-823A-9E23F7AA0FAD</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, is interviewed regarding funding for Alzheimer's research. &amp;nbsp;(BBC Radio Wales, 2.2.10)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff Scientific Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>635F633A-7350-44E5-A8D9-3E8E52C3485B</gtr:id><gtr:impact>Talk entitled - The Genetics underlying late-onset Alzheimer's Disease

Not Known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B9A6551B-CF21-488A-80DD-F198DD185CCF</gtr:id><gtr:impact>We hosted a public meeting, supported by the Alzheimer's Research Trust, in September 2007. In addition to events hosted within the University we have also presented our research findings to carers, and individuals with AD at Alzheimer's Society regional meetings in Cardiff, Swansea, Blackwood and Caerleon and to the members of the Newport Carers Group and County Hosptial Carers Group, Pontypool.

These meetings contribute substantially to engaging the public in our research.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2 new genetic variations linked with Alzheimer's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5119AB81-EEE2-41D4-B977-ADBA30FE0DBF</gtr:id><gtr:impact>An international collaboration of scientists, including expertise from Cardiff University, has uncovered two new genetic variations linked with Alzheimer's, opening up new research avenues into the disease. The two newly discovered genetic variations do not predict a person's risk of developing Alzheimer's, but the authors of the paper, which appears in The Journal of the American Medical Association (JAMA) speak of new valuable insights for scientists working on the disease. Professor Julie Williams, Cardiff University, is a principal investigator of the study, led by Professor Monique Breteler, University Medical Center Rotterdam. The research also builds on the discovery led by Professor Williams last year of the first new genes associated with Alzheimer's in a generation.


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Global media coverage</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1F1B1F1B-751B-48E2-ABB3-453977FB2BE1</gtr:id><gtr:impact>In September 2009 we published evidence of two new genes which are associated with susceptibility to Alzheimer's disease. This research generated substantial media interest both nationally and internationally. To see the BBC coverage of this story please visit: http://news.bbc.co.uk/1/hi/wales/8239773.stm. The story was covered in over 70 high quality publications (a full list is provided at the bottom this text). In addition, these findings have recently been recognised as one of the world's top 10 scientific breakthroughs of 2009 by Time magazine. See: http://www.time.com/time/specials/packages/article/0,28804,1945379_1944376_1944408,00.html Publications: Sky News Channel 4 News BBC Wales News ITV Wales Pittsburgh post - Gazette Daily Express Swansea Sound Washington Post New York Times Daily Telegraph Western Mail South Wales Echo The Independent The Irish Times Financial Times Sydney Morning Herald Ottawa Citizen Daily Mail Guardian The Mirror Nottingham Journal The Money Times The Sun Sindh Today Science Daily Belfast Telegraph Emax Health Malaysia News net Digital Journal Cambridge News Online Alzheimer's Society Real Radio Red Dragon Boston Globe Calgary Sun Norwich Evening News The Gov Monitor The Spokesman Review Food consumer Times of India Science News Medical News Today Top News NHS News Nature.com Blog Efitness.now Merinews Science Alert Pulse Today AHN Richmond Times - Dispatch The Birmingham News, Alabama Newsday, Melville NY The San Diego Union - Tribune, California El Nuevo Herald The Daily Gazette, New York St Paul's Pioneer Press Valley News Dispatch Chattanooga Times Free Press St Petersburg Times The Virginian - Pilot The Providence Journal The Gainsville Sun San Jose Mercury News The Journal Gazette Daily Times - Call The Tribune Visit Bulgaria Australian Ageing Agenda The News - Enterprise Ethiopian Review The Times - Tribune, PA South Florida Sun Sentinel ABC7 St Charles County Business Record The St Louis Countian

Such extensive media coverage has raised the profile of Alzheimer's disease and dementia research. Since the articles were published we have received numerous enquiries from members of the public wanting to contribute to our research. It has also promoted our own research nationally and internationally and we have developed collaborations as a direct result of this media coverage.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>U3A Brecon</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9510B091-12D8-4151-B226-5A45DE92043B</gtr:id><gtr:impact>Dissemination of Alzheimers research findings

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Alzheimer's genes revealed</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3CBFC0E7-C18F-4E65-AFB1-6D1EB97D2581</gtr:id><gtr:impact>Two potentially key genes linked to the development of Alzheimer's disease have been uncovered by UK researchers. Covered by major news channels including the BBC

Nationwide media coverage will lead to increased public knowledge</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Westminster visit - Dementia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C804FFD5-F323-4DCD-BBC0-06D4638BE4DA</gtr:id><gtr:impact>Dissemination of research findings to parliamentarians

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ART Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1FFD5937-FFBE-4E16-9626-6ECECC072582</gtr:id><gtr:impact>Presented research findings as part of the ART public lecture &amp;quot;New Alzheimer's genes: What do they mean?&amp;quot;

Not Known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kings College London Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9345E2CB-B1DD-49A0-8352-14B1D5DF8C5B</gtr:id><gtr:impact>Delivered talk entitled - Psychiatric Genetics: Everything you always wanted to know but were afraid to ask

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WAG Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7ECDD61E-9CA3-4A66-AEF5-DACC31A70FCE</gtr:id><gtr:impact>Presented recent research findings to policy makers

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New susceptibility genes for Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A7C83AD9-B48B-487A-8FA5-3F605554D799</gtr:id><gtr:impact>Invited speaker - Eisai Symposium in Neuroscience (Dementia and Cognitive Dysfunction) - May 2010


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ART Event - Bournemouth</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C5034B49-2FD4-4A3B-BEFE-7D9466941E02</gtr:id><gtr:impact>Disseminating research findings to research participants

not know</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Defining the genetic architecture of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1D78C15F-39E3-4E9B-AC30-0B843A19E40F</gtr:id><gtr:impact>Alzheimer's Research Trust Research Day - Manchester ART Centre, Chancellors conference centre 27th January 2011 - Keynote speaker


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Marshall Scholars</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6D4C8F0E-58A2-4146-A166-607D9AB7D62F</gtr:id><gtr:impact>A talk entitled &amp;quot;New genetic findings in Alzheimers Disease&amp;quot; was presented to a group of Marshall Scholars

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Seminar Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF15E66B-AE68-4FA8-AD3C-DD766E06D7A8</gtr:id><gtr:impact>Invited speaker - Seminar Series,University of Oxford - June 2010


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Researchers Find Two More Genetic Risk Factors For Alzheimer's Disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>28B57F6D-B180-4910-8ACD-FCA1C81B506C</gtr:id><gtr:impact>Widespread worldwide broadcast, press and online coverage of a major new study into Alzheimer's led by researchers at Cardiff University. Including BBC, Channel 4, SKY and ABC news, The Telegraph, The Times, The Telegraph, The New York Times and all over major news channels / papers.

&amp;quot;The MRC Centre and research like this is changing our understanding of what causes the common form of Alzheimer's disease and provides valuable new leads in the race to find treatments and possibly cures.

&amp;quot;It also shows that other genes can be identified using this method, and we are already planning a larger study involving 60,000 people, which can be achieved within the next year.

&amp;quot;It is also important to recognise the contribution many Welsh people who have acted as subjects for this research over the years.&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Will identifying susceptibility genes for Alzheimer's disease increase healthy ageing?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>89DC5399-171B-4CB2-8F5C-A8F900DDF8FD</gtr:id><gtr:impact>Invited speaker - United Nations Older Person's Day - Promoting active and healthy ageing - Cardiff, 30th September 2010 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NGFN Symposium - Bonn</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>510DFE8C-EC3F-476A-9218-7305A823FF74</gtr:id><gtr:impact>Delivered talk entitled - Molecular Genetics in Alzheimer's Dementia

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Zeurs Austria - Drugs Genetics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ADF0FF97-FBEC-432F-9B39-D447A5D79828</gtr:id><gtr:impact>Presented talk entitled - Defining the genetic architecture for AD

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Welsh language champions in NHS health boards</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2C5BB372-08E4-407B-B1F3-2E11023B4BD3</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine comments on plans to appoint Welsh language champions in NHS health boards. (Western Mail, 7/6/10, p25)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual ART Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D48F8EA1-EC57-4AD0-BEAD-22B72538D7C5</gtr:id><gtr:impact>Attended and presented at the annual ART conference

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimers Society Visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B93325A1-2DD1-4AD5-B2F4-4629395CF040</gtr:id><gtr:impact>presented research findings to representatives of ART at a visit hosted by the Dean of Medicine, Cardiff University

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>It is time to make mental health research a funding priority</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4189C9F4-F6DC-4CF4-AD83-87E84BDC9F01</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, argues in an essay that it is time to make mental health research a funding priority. Cardiff University has committed to this in creating the new Neuroscience and Mental Health Research Institute - and Professor Williams calls on other decision makers and funders to do likewise. (W.Mail, 9.8.10 p26) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Llandough Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>62C7AACB-92C1-4D77-84F9-3279AEE20F8D</gtr:id><gtr:impact>Dissemination of recent findings

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The International Genomics of Alzheimer's Project (IGAP)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>670B8409-D322-4EF8-A2B7-2BAD1A416D2C</gtr:id><gtr:impact>A leading University expert in identifying genes that cause Alzheimer's disease will meet with some of the world's other figures for the first-time in Paris (Friday 19th November) in a bid help share knowledge and speed-up the genetic fight against the disease. The International Genomics of Alzheimer's Project (IGAP) is a major international consortium which brings together for the first time four of the world's leading research centres - including &amp;nbsp;Professor Julie Williams, School of Medicine, who leads the Genetic and Environmental Risk in Alzheimer's Disease (GERAD).


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Funding for Alzheimer's research</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ED7D8165-4497-44E7-A9E6-E1A8BF63F908</gtr:id><gtr:impact>Scientists in Wales researching the causes of dementia are at a &amp;quot;major disadvantage&amp;quot; because the nation does not fund such projects says Professor Julie Williams, School of Medicine. (Western Mail, 4/2/10, p14) Professor Williams is also interviewed about funding for Alzheimer's research. &amp;nbsp;(BBC Wales News, 4/2/10)


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ART - Westminster</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5F31BF86-5734-4D40-BBF1-42B8C47D3969</gtr:id><gtr:impact>Dissemination of research findings to parliamentarians

not known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UN Older Persons Day - Cardiff</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7AB3F09-9970-42BA-A2D1-14CDCAB1050D</gtr:id><gtr:impact>Delivered talk entitled - Will identifying susceptibility genes for Alzheimer's Disease increase healthy aging?

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EISA Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>86922FE1-2934-4844-8266-051F8FBDBDC5</gtr:id><gtr:impact>Delivered talk entitled - Dementia and Cognitive Dysfunction

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Today Programme</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BDACF0A6-CA21-4598-BB0C-132E232BE418</gtr:id><gtr:impact>JW on BBC Radio 4's Today programme talking
about her discovery of two new genes associated with Alzheimer's disease which could provide
valuable new leads in the race to find treatments and possibly cures for the devastating condition

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff experts call for Alzheimer's action</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>154C0DC1-29DE-4CB5-8D1C-0B576BEB785B</gtr:id><gtr:impact>Cardiff experts have been at the forefront of calls to step up the battle against Alzheimer's Disease in the press and on national television following a leading international conference on the disease. Nationwide media coverage including the BBC news

Will lead to increased public awareness</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Distribution of news letter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CB83A3F0-1C0B-4286-9751-CEDAAC752BB2</gtr:id><gtr:impact>We distribute a 4-8 page newsletter annually to participants in our research, their families and healthcare professionals At present just over 1000 people receive our newsletter.

The newsletter helps engage the public in our research and we receive a large amount of positive feedback from it. We also hope that the newsletter has a positive impact on retention of participants in longitudinal aspects of our research.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Awarded ?800K to lead new genetic research into Alzheimer's</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5CD67053-BCA3-433D-AAF0-225D5ECDF773</gtr:id><gtr:impact>Professor Julie Williams, School of Medicine, has been awarded &amp;pound;800K to lead new genetic research into Alzheimer's (Business Weekly, 14.10.10) 


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Time Magazine - Medical breakthroughs of 2009</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>05776FEB-C0A3-41D5-AC38-5E4F75970282</gtr:id><gtr:impact>A key University study which helped uncover two new genes associated with Alzheimer's disease has been recognised as one of the top 10 medical breakthroughs of 2009 by TIME Magazine.

International acknowledgement of research findings.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genome wide association study of Alzheimer's disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C94190C7-7A2B-4B4D-8D87-3EC1047CB0D4</gtr:id><gtr:impact>Invited Plenary - International Conference on Alzheimer's disease (ICAD) - Vienna - July 2009


Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>52645</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial Collaborative Studentship - A novel approach to identifying new susceptibility genes for late on-set Alzheimer's disease and its sub components</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>AE0B161B-DAE4-4A82-80D8-AA2EC34D0B3C</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>203000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Grant for the establishment of an ART AD research centre</gtr:description><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>CEBFC36E-0BA8-4E03-90B9-63A215F8C4BA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>404390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ABBUK Brains for Dementia Research Programme (extension)</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Alzheimer?s Brain Bank UK (ABBUK)</gtr:fundingOrg><gtr:fundingRef>504291</gtr:fundingRef><gtr:id>937238FB-CE43-4F6D-8C78-B7AE93FEBB4B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>148348</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Translating new susceptibility genes for Alzheimer's Disease through clinical characterisation and epidemiology/Welsh Assembly Government</gtr:description><gtr:fundingOrg>National Institute for Social Care and Health Research Clinical Research Centre (NISCHR CRC)</gtr:fundingOrg><gtr:id>5F1E912A-5DC7-4235-BFB2-9D34232E5E76</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251460</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dyslexia genes and neurobiological pathways (NEURODYS)</gtr:description><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>4ABCB8EF-98DF-4F47-930A-48CFE052B1DA</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>168514</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evaluation of candidate genomic regions to determine genetic pedisposition in populations of Alzheimer's patients</gtr:description><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>8794B547-D11A-4451-9081-8EE731B2D309</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161915</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Brains for dementia research</gtr:description><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>29F6AB2A-C126-4123-9464-A0BD0F923CDD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>286504</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (A Powerful, Genome-Wide Association Scan for Susceptibility Genes for late-onset Alzheimer's disease)</gtr:description><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>02956212-9068-4DE3-9B33-F41281626463</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>532000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical collection supply agreement to investigate the genetics of Alzheimer's disease/Glaxosmithkline Research &amp;amp; Development</gtr:description><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>31DF3612-F166-42CC-9F0A-F48132F19C6F</gtr:id><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>41674</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NEURODEM/National Assembly for Wales via Bangor University</gtr:description><gtr:fundingOrg>National Institute for Social Care and Health Research Clinical Research Centre (NISCHR CRC)</gtr:fundingOrg><gtr:id>7F0DAAFA-C405-4FC9-AA89-48718C3E1990</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The work has also been published and has achieved a huge amount of media coverage. This discovery of three further genes associated with Alzheimer's disease could provide valuable new leads in the race to find treatments and possibly cures for the devastating condition. This patent application resulted from Julie Williams, Professor of Neuropsychological Genetics and Professor Mike Owen, Professor and Head of MRC Centre, completing the largest-ever joint Alzheimer's disease genome-wide association study (GWAS) involving 16,000 individuals. The patenting of theseSNPS is still in progress and a reveiew is currently underway to identify the best route to exploitation of the technology.</gtr:description><gtr:id>9D4D8811-0D8D-4E8B-A28F-314B4CBF1953</gtr:id><gtr:impact>This has had huge worldwide impact through media coverage and was originally highlighted in the press with the discovery of an additional 5 genes. We are currently in the process of seeking a licencee for the patented technology which encompasses a diagnostic test for the protected gene SNPs. Recent advances include generation of a polygenic score including the licensed SNPs for the detection of AD risk. We are working together with industry on basic genetic testing, cohort studies, cognitive test providers and pathway specific therapies for new ways in which to combat Alzheimer's disease.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2011001135; NZ 596614; CAN 2,766,876; JP 2012-516841 and JP 2013-164509 ;AUS  201001208; US 13/376,485 and US 13/886,473; EP 10747062.7; CN 201080029259.9 and CN 201310280889.9; HK 12110195.8; UK 2766876</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Diagnosis of Alzheimer's Disease</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientific Advisor to Alzheimer's Research Trust</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>66FD999A-41F7-44A8-B8F2-69A508A7217B</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health Advisory Group on Dementia</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F9958B73-C51B-48ED-97CE-6B6481691314</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Department of Health Advisory Group on Dementia</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6241A33E-52F6-446A-A8AA-243F1C1F27B6</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Welsh Assembly Government Advisory Group on Dementia</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>D306A1F1-C411-4310-AC83-59D92D2303CB</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Genome-wide association study data of over 3,000 AD cases and 7,000 controls</gtr:description><gtr:id>DE11CCA5-2145-46A5-94D8-BC6A55CAC421</gtr:id><gtr:impact>multiple publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GERAD GWAS</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Mega-meta analysis data of over 17,000 AD cases and 30,000 controls</gtr:description><gtr:id>6028D135-B9E6-40F6-9757-DA8DA198BEF6</gtr:id><gtr:impact>Lambert et al. 2013 (PMID:24162737), Escott-Price et al. 2014(in press), Farrer et al. 2014 (submitted)</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IGAP dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have recently created a brain bank based upon the longitudinal sample, to provide the wider research community with multiple tissue samples on well characterised individuals.</gtr:description><gtr:id>E27D1CBE-E39C-491E-8E2E-938BF1080003</gtr:id><gtr:impact>Multiple publications and media coverage</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Brain Bank - Alzheimers</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>With 80,000 variants included to create a measure of risk of Alzheimer's disease, the polygenic score is an excellent predictive tool to determine case/control status with high accuracy. The polygenic score encompasses the majority of genetic risk of disease, and can be fine-tuned to identify the pathways involved in disease, for example, immune cell activity or endocytosis.</gtr:description><gtr:id>B70731B2-12E8-483B-99D0-4D66A3674D66</gtr:id><gtr:impact>We are working to translate this method from the basic science environment in which it was created into a predictive tool used to select participants for clinical trials, based on their disease status and type. We are currently in discussions with a number of potential collaborators to take this forward.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Polygenic score</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1555F411-717F-4C61-BAAD-0AC418A13304"><gtr:id>1555F411-717F-4C61-BAAD-0AC418A13304</gtr:id><gtr:title>Premorbid personality and behavioral and psychological symptoms in probable Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6b1d47c1305257fbe8c8b275c862eb6"><gtr:id>c6b1d47c1305257fbe8c8b275c862eb6</gtr:id><gtr:otherNames>Archer N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-7481</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4764731A-7B01-4B49-B178-79653A4A6B15"><gtr:id>4764731A-7B01-4B49-B178-79653A4A6B15</gtr:id><gtr:title>Candidate gene association study of insulin signaling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3980E746-3613-45DC-9BAB-8B952B885918"><gtr:id>3980E746-3613-45DC-9BAB-8B952B885918</gtr:id><gtr:title>A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e61b968513bed9688e49b1f1a52e38d"><gtr:id>8e61b968513bed9688e49b1f1a52e38d</gtr:id><gtr:otherNames>Grupe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30DA6BA4-3640-4977-BE0E-4141112D1817"><gtr:id>30DA6BA4-3640-4977-BE0E-4141112D1817</gtr:id><gtr:title>Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairs.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d280b5ee2bc9de3219f20962eff94cb"><gtr:id>1d280b5ee2bc9de3219f20962eff94cb</gtr:id><gtr:otherNames>Blom ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B492F1FB-7C53-478D-AFB6-585407146276"><gtr:id>B492F1FB-7C53-478D-AFB6-585407146276</gtr:id><gtr:title>Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/409c0c9fd237532d04d3b40b2b89a73f"><gtr:id>409c0c9fd237532d04d3b40b2b89a73f</gtr:id><gtr:otherNames>Kauwe JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FE09F83-0555-4A6A-B476-55EABA1C2B33"><gtr:id>6FE09F83-0555-4A6A-B476-55EABA1C2B33</gtr:id><gtr:title>Polymorphisms in the phosphate and tensin homolog gene are not associated with late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11CF59AD-C673-4E8E-AB57-253D75D8CD88"><gtr:id>11CF59AD-C673-4E8E-AB57-253D75D8CD88</gtr:id><gtr:title>Pinpointing key mechanisms in Alzheimer's disease development.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/491db2ad2037f9337d5af0a5ea667b45"><gtr:id>491db2ad2037f9337d5af0a5ea667b45</gtr:id><gtr:otherNames>Williams J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C71B1DD-33FC-4984-B475-D89399051187"><gtr:id>7C71B1DD-33FC-4984-B475-D89399051187</gtr:id><gtr:title>The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in A?-expressing Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/36688dfd02cdf9038c075b02a278b29d"><gtr:id>36688dfd02cdf9038c075b02a278b29d</gtr:id><gtr:otherNames>Khabirova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9743E20E-2662-40C0-B32D-1B9A7B72267A"><gtr:id>9743E20E-2662-40C0-B32D-1B9A7B72267A</gtr:id><gtr:title>Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/531EC787-275D-4624-B377-7CAEFADCC371"><gtr:id>531EC787-275D-4624-B377-7CAEFADCC371</gtr:id><gtr:title>Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Geriatrics Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-8614</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/19B468A7-0334-405A-8E78-360ACB245387"><gtr:id>19B468A7-0334-405A-8E78-360ACB245387</gtr:id><gtr:title>Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6B03E9DE-5E63-4375-A3F2-3322451654D1"><gtr:id>6B03E9DE-5E63-4375-A3F2-3322451654D1</gtr:id><gtr:title>DAPK1 variants are associated with Alzheimer's disease and allele-specific expression.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6D640D9-3ADD-4B05-AF65-C98CF39C2AB2"><gtr:id>B6D640D9-3ADD-4B05-AF65-C98CF39C2AB2</gtr:id><gtr:title>Identification of Alzheimer risk factors through whole-genome analysis.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0137BAEF-1462-49AC-80FF-56656FB4B74D"><gtr:id>0137BAEF-1462-49AC-80FF-56656FB4B74D</gtr:id><gtr:title>GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C991C0E-2DD8-4377-B0A6-5BD83862F26B"><gtr:id>4C991C0E-2DD8-4377-B0A6-5BD83862F26B</gtr:id><gtr:title>Genome-wide analysis of genetic loci associated with Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfc006d0c2de88dc268cd20cc998e443"><gtr:id>bfc006d0c2de88dc268cd20cc998e443</gtr:id><gtr:otherNames>Seshadri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF477BBA-2567-4C87-825F-BF5A9311F47A"><gtr:id>FF477BBA-2567-4C87-825F-BF5A9311F47A</gtr:id><gtr:title>Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5109e1a98eef0b7d0fee05867d6f9d86"><gtr:id>5109e1a98eef0b7d0fee05867d6f9d86</gtr:id><gtr:otherNames>Morgan AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B4D414D5-E075-4CB6-8DEA-6878B596DDEC"><gtr:id>B4D414D5-E075-4CB6-8DEA-6878B596DDEC</gtr:id><gtr:title>A multi-center study of ACE and the risk of late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f70642dcb9ec3c67096c9c651cc1b6dc"><gtr:id>f70642dcb9ec3c67096c9c651cc1b6dc</gtr:id><gtr:otherNames>Belbin O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E17EA5F2-B379-4923-98FF-9E50C71D2921"><gtr:id>E17EA5F2-B379-4923-98FF-9E50C71D2921</gtr:id><gtr:title>Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd8023311d4c7e4e081ffa16b1b8d11d"><gtr:id>bd8023311d4c7e4e081ffa16b1b8d11d</gtr:id><gtr:otherNames>Smemo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E020F0D-E182-454F-8840-8ABB2CE1CF5F"><gtr:id>6E020F0D-E182-454F-8840-8ABB2CE1CF5F</gtr:id><gtr:title>Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9af579e58c96e7ec539350c53d976d5b"><gtr:id>9af579e58c96e7ec539350c53d976d5b</gtr:id><gtr:otherNames>Inkster B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78044A97-B5FF-4729-A757-E149B93EBC43"><gtr:id>78044A97-B5FF-4729-A757-E149B93EBC43</gtr:id><gtr:title>Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F288B85-2467-439D-9E92-A57F99EA9912"><gtr:id>1F288B85-2467-439D-9E92-A57F99EA9912</gtr:id><gtr:title>Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8e61b968513bed9688e49b1f1a52e38d"><gtr:id>8e61b968513bed9688e49b1f1a52e38d</gtr:id><gtr:otherNames>Grupe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BA39AE5-1AA2-44D9-A6DD-0A9F01F027D0"><gtr:id>7BA39AE5-1AA2-44D9-A6DD-0A9F01F027D0</gtr:id><gtr:title>Interaction between the ADAM12 and SH3MD1 genes may confer susceptibility to late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9310cf284c8313db35d3785d3e32077"><gtr:id>a9310cf284c8313db35d3785d3e32077</gtr:id><gtr:otherNames>Harold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE4BB056-9890-4BE8-B04C-3E1D71E6BC71"><gtr:id>CE4BB056-9890-4BE8-B04C-3E1D71E6BC71</gtr:id><gtr:title>Meta-analysis of the association between variants in SORL1 and Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88c5faf6556abf4b73f5fe11793f817a"><gtr:id>88c5faf6556abf4b73f5fe11793f817a</gtr:id><gtr:otherNames>Reitz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52C9E426-30C5-4802-921A-0AC1CA0D92B0"><gtr:id>52C9E426-30C5-4802-921A-0AC1CA0D92B0</gtr:id><gtr:title>Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c894e9040c244eeb8bc2e4e4cde5a6ea"><gtr:id>c894e9040c244eeb8bc2e4e4cde5a6ea</gtr:id><gtr:otherNames>Foy CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD66FD9B-2658-4D76-9E4C-E157EAB373F8"><gtr:id>DD66FD9B-2658-4D76-9E4C-E157EAB373F8</gtr:id><gtr:title>SORL1 variants and risk of late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd75dbe105014309cbdded985198a393"><gtr:id>bd75dbe105014309cbdded985198a393</gtr:id><gtr:otherNames>Li Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D000526-3B89-44A2-86C0-C536531A11D3"><gtr:id>0D000526-3B89-44A2-86C0-C536531A11D3</gtr:id><gtr:title>A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Pharmacogenetics and genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9310cf284c8313db35d3785d3e32077"><gtr:id>a9310cf284c8313db35d3785d3e32077</gtr:id><gtr:otherNames>Harold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1744-6872</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0727FDFB-953C-4C66-8726-7CC0DF065CF3"><gtr:id>0727FDFB-953C-4C66-8726-7CC0DF065CF3</gtr:id><gtr:title>Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC239F4D-8359-4AD4-9BB6-B9C2CD96D208"><gtr:id>FC239F4D-8359-4AD4-9BB6-B9C2CD96D208</gtr:id><gtr:title>A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a4db89997b8ce0c07217c5879f816fb"><gtr:id>5a4db89997b8ce0c07217c5879f816fb</gtr:id><gtr:otherNames>Deming Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66374A02-87B7-4A2C-9F59-6DD354B6DC53"><gtr:id>66374A02-87B7-4A2C-9F59-6DD354B6DC53</gtr:id><gtr:title>Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E9B150B-6B03-4BF2-A861-87DA55FA1FA8"><gtr:id>9E9B150B-6B03-4BF2-A861-87DA55FA1FA8</gtr:id><gtr:title>Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD4384E4-91F7-4871-ACAC-436A5F5E45D7"><gtr:id>AD4384E4-91F7-4871-ACAC-436A5F5E45D7</gtr:id><gtr:title>An association study of common variation at the MAPT locus with late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7e80d80b3093294af737e741cac88904"><gtr:id>7e80d80b3093294af737e741cac88904</gtr:id><gtr:otherNames>Abraham R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/18A98F2C-A068-47AB-BCE5-D972AF383282"><gtr:id>18A98F2C-A068-47AB-BCE5-D972AF383282</gtr:id><gtr:title>A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/028d3b2ceed7be9c07d74b670071bc7f"><gtr:id>028d3b2ceed7be9c07d74b670071bc7f</gtr:id><gtr:otherNames>Chapman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E48FB52B-6FA0-4F16-8AC7-8D645688A3F0"><gtr:id>E48FB52B-6FA0-4F16-8AC7-8D645688A3F0</gtr:id><gtr:title>Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9310cf284c8313db35d3785d3e32077"><gtr:id>a9310cf284c8313db35d3785d3e32077</gtr:id><gtr:otherNames>Harold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22282DB9-BE19-4666-B083-A82064F51132"><gtr:id>22282DB9-BE19-4666-B083-A82064F51132</gtr:id><gtr:title>Genome-wide association interaction analysis for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c5650dbecb9504886b4a636f656329a"><gtr:id>4c5650dbecb9504886b4a636f656329a</gtr:id><gtr:otherNames>Gusareva ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5FA9D6B-0C60-476E-BF38-1B3DA04E7978"><gtr:id>A5FA9D6B-0C60-476E-BF38-1B3DA04E7978</gtr:id><gtr:title>Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d280b5ee2bc9de3219f20962eff94cb"><gtr:id>1d280b5ee2bc9de3219f20962eff94cb</gtr:id><gtr:otherNames>Blom ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/19AB1B05-47C1-4A31-AB61-046B55E71365"><gtr:id>19AB1B05-47C1-4A31-AB61-046B55E71365</gtr:id><gtr:title>Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3A990B5-15E1-4209-A0B6-0610AEE3F7BA"><gtr:id>A3A990B5-15E1-4209-A0B6-0610AEE3F7BA</gtr:id><gtr:title>Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8734e4ce1ec2fe4159e099af004bc0e0"><gtr:id>8734e4ce1ec2fe4159e099af004bc0e0</gtr:id><gtr:otherNames>Kwok JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1CCDE91-79B7-4929-A0F0-38E2B2C1A0D9"><gtr:id>E1CCDE91-79B7-4929-A0F0-38E2B2C1A0D9</gtr:id><gtr:title>Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DDBB1E6-7161-4DD0-80F2-191996B2159D"><gtr:id>9DDBB1E6-7161-4DD0-80F2-191996B2159D</gtr:id><gtr:title>Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5109e1a98eef0b7d0fee05867d6f9d86"><gtr:id>5109e1a98eef0b7d0fee05867d6f9d86</gtr:id><gtr:otherNames>Morgan AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C8D6FD3-B7BB-40AE-8D49-83DF28203549"><gtr:id>2C8D6FD3-B7BB-40AE-8D49-83DF28203549</gtr:id><gtr:title>Distribution and expression of picalm in Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dd1c9e5d1b95764179492b943002f2d9"><gtr:id>dd1c9e5d1b95764179492b943002f2d9</gtr:id><gtr:otherNames>Baig S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BF31774-19E4-476E-818D-6F2B0FB66FF6"><gtr:id>7BF31774-19E4-476E-818D-6F2B0FB66FF6</gtr:id><gtr:title>Alzheimer's disease genetics: current knowledge and future challenges.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B587C911-A270-4E5B-87B7-E7FD5816FF95"><gtr:id>B587C911-A270-4E5B-87B7-E7FD5816FF95</gtr:id><gtr:title>Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70abf00631c3208bb727c810ad3900db"><gtr:id>70abf00631c3208bb727c810ad3900db</gtr:id><gtr:otherNames>Pagnamenta AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E54AD79A-A6AB-4A7E-8B29-56F99259FDE1"><gtr:id>E54AD79A-A6AB-4A7E-8B29-56F99259FDE1</gtr:id><gtr:title>Education, occupation and retirement age effects on the age of onset of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>International journal of geriatric psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ccda11cca9d7a6ebd508c61b977002b0"><gtr:id>ccda11cca9d7a6ebd508c61b977002b0</gtr:id><gtr:otherNames>Lupton MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-6230</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6523481D-D5A7-45DA-A938-33527272E2A5"><gtr:id>6523481D-D5A7-45DA-A938-33527272E2A5</gtr:id><gtr:title>Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/409c0c9fd237532d04d3b40b2b89a73f"><gtr:id>409c0c9fd237532d04d3b40b2b89a73f</gtr:id><gtr:otherNames>Kauwe JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0CA41CF9-C97F-4B71-85C6-5EEB86BE8283"><gtr:id>0CA41CF9-C97F-4B71-85C6-5EEB86BE8283</gtr:id><gtr:title>Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A009EA8F-DADD-4B04-8D75-3AF29FFD4FDB"><gtr:id>A009EA8F-DADD-4B04-8D75-3AF29FFD4FDB</gtr:id><gtr:title>Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3b2aaf1b7109ac42d9d9d55641e4ae7f"><gtr:id>3b2aaf1b7109ac42d9d9d55641e4ae7f</gtr:id><gtr:otherNames>Hamshere ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01A25345-EC48-4C81-A5A3-9FC03DD34EE0"><gtr:id>01A25345-EC48-4C81-A5A3-9FC03DD34EE0</gtr:id><gtr:title>SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47D95D63-1521-4693-AF40-F47359B3DBE4"><gtr:id>47D95D63-1521-4693-AF40-F47359B3DBE4</gtr:id><gtr:title>Genome-wide association study of Alzheimer's disease with psychotic symptoms.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11A2D375-1F0B-4BC0-9985-C93D3713E82A"><gtr:id>11A2D375-1F0B-4BC0-9985-C93D3713E82A</gtr:id><gtr:title>Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6131149cdce87664573322b7d4900f00"><gtr:id>6131149cdce87664573322b7d4900f00</gtr:id><gtr:otherNames>Sch?rmann B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A4EF4EA-62BE-4ACC-B679-F8958DA4B670"><gtr:id>9A4EF4EA-62BE-4ACC-B679-F8958DA4B670</gtr:id><gtr:title>Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c8d2dccb5c3338979e7f8a8641956f6"><gtr:id>0c8d2dccb5c3338979e7f8a8641956f6</gtr:id><gtr:otherNames>Proitsi P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F50B03D1-AC32-45CD-8D1A-49F5D40D1671"><gtr:id>F50B03D1-AC32-45CD-8D1A-49F5D40D1671</gtr:id><gtr:title>A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.</gtr:title><gtr:parentPublicationTitle>BMC medical genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7e80d80b3093294af737e741cac88904"><gtr:id>7e80d80b3093294af737e741cac88904</gtr:id><gtr:otherNames>Abraham R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1755-8794</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300429</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>